AIMS ALLERGY AND IMMUNOLOGY : Impact Factor & More
eISSN: 2575-615XpISSN: 2575-615X
Open AccessShare this on:
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on AIMS ALLERGY AND IMMUNOLOGY
AIMS ALLERGY AND IMMUNOLOGY Journal Specifications
Indexed in the following public directories
Web of Science 
DOAJ
| Overview | |
| Publisher | AMER INST MATHEMATICAL SCIENCES-AIMS |
| Language | English |
| Frequency | Quarterly |
| Publication Time | 4 |
| Editorial Review Process | Peer review |
| General Details | |
| Language | English |
| Frequency | Quarterly |
| Publication Start Year | 2017 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY |
| OA statement | Visit website |
View less
Planning to publish in AIMS ALLERGY AND IMMUNOLOGY ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in AIMS ALLERGY AND IMMUNOLOGY
Dynamics of CD40 ligand levels in newly diagnosed and treated tuberculosis patients: An evaluation of sCD40L concentration and CD4<sup>+</sup> T cell surface expression
- 1 Jan 2026
- AIMS Allergy and Immunology
Bacterial outer membrane vesicles: A scoping review on their dual roles in immunity and disease (2020–2025)
- 1 Jan 2026
- AIMS Allergy and Immunology
Annual Report 2025
- 1 Jan 2026
- AIMS Allergy and Immunology
Recurrent Kawasaki disease in children: Four case reports
- 1 Jan 2025
- AIMS Allergy and Immunology
Interpreting autoimmune risks in the COVID-19 vaccine literature: A two-phase qualitative coding protocol on biological mechanisms and epistemic integrity
- 1 Jan 2025
- AIMS Allergy and Immunology
Clinical advancements of biologic agents in the treatment of Kawasaki disease based on its pathogenesis
- 1 Jan 2025
- AIMS Allergy and Immunology
Dynamics of CD40 ligand levels in newly diagnosed and treated tuberculosis patients: An evaluation of sCD40L concentration and CD4<sup>+</sup> T cell surface expression
- 1 Jan 2026
- AIMS Allergy and Immunology
Bacterial outer membrane vesicles: A scoping review on their dual roles in immunity and disease (2020–2025)
- 1 Jan 2026
- AIMS Allergy and Immunology
Annual Report 2025
- 1 Jan 2026
- AIMS Allergy and Immunology
Recurrent Kawasaki disease in children: Four case reports
- 1 Jan 2025
- AIMS Allergy and Immunology
Interpreting autoimmune risks in the COVID-19 vaccine literature: A two-phase qualitative coding protocol on biological mechanisms and epistemic integrity
- 1 Jan 2025
- AIMS Allergy and Immunology
Clinical advancements of biologic agents in the treatment of Kawasaki disease based on its pathogenesis
- 1 Jan 2025
- AIMS Allergy and Immunology
FAQs on AIMS ALLERGY AND IMMUNOLOGY
How long has AIMS ALLERGY AND IMMUNOLOGY been actively publishing? 
What is the publishing frequency of AIMS ALLERGY AND IMMUNOLOGY?
How many articles did AIMS ALLERGY AND IMMUNOLOGY publish last year?
What is the eISSN & pISSN for AIMS ALLERGY AND IMMUNOLOGY?
Who is the publisher of AIMS ALLERGY AND IMMUNOLOGY?
